Skip to content
  • CONTACT US
  • CAREERS
  • Share
Allogene Logo
  • PIPELINE
    • AlloCAR T PRODUCT PIPELINE
    • THE ALPHA3 TRIAL
    • THE RESOLUTION TRIAL
    • DATABRIEF
    • EXPANDED ACCESS
  • SCIENCE
    • NEXT REVOLUTION IN CELL THERAPY
    • PLATFORM FOR TOMORROW
    • ON-DEMAND AVAILABILITY
    • SCIENTIFIC PUBLICATIONS
  • ABOUT US
    • AT A GLANCE
    • MANAGEMENT TEAM
    • BOARD OF DIRECTORS
    • SCIENTIFIC ADVISORS
    • PARTNERS
    • CORPORATE RESPONSIBILITY
  • NEWS CENTER
    • PRESS RELEASES
    • EVENTS
    • PERSPECTIVES
    • SOCIAL MEDIA
    • COMMUNITY GUIDELINES
  • INVESTORS
    • IR OVERVIEW
    • NEWS & EVENTS
      • PRESS RELEASES
      • EVENTS
      • PRESENTATIONS
    • STOCK INFORMATION
      • STOCK QUOTE & CHART
      • HISTORIC PRICE LOOKUP
      • INVESTMENT CALCULATOR
    • CORPORATE GOVERNANCE
      • DOCUMENTS & CHARTERS
      • BOARD OF DIRECTORS
      • MANAGEMENT
      • COMMITTEE COMPOSITION
    • FINANCIALS & FILINGS
      • SEC FILINGS
    • RESOURCES
      • INVESTOR FAQs
      • EMAIL ALERTS
      • IR INQUIRY
  • PIPELINE
    • AlloCAR T PRODUCT PIPELINE
    • THE ALPHA3 TRIAL
    • THE RESOLUTION TRIAL
    • DATABRIEF
    • EXPANDED ACCESS
  • SCIENCE
    • NEXT REVOLUTION IN CELL THERAPY
    • PLATFORM FOR TOMORROW
    • ON-DEMAND AVAILABILITY
    • SCIENTIFIC PUBLICATIONS
  • ABOUT US
    • AT A GLANCE
    • MANAGEMENT TEAM
    • BOARD OF DIRECTORS
    • SCIENTIFIC ADVISORS
    • PARTNERS
    • CORPORATE RESPONSIBILITY
  • NEWS CENTER
    • PRESS RELEASES
    • EVENTS
    • PERSPECTIVES
    • SOCIAL MEDIA
    • COMMUNITY GUIDELINES
  • INVESTORS
    • IR OVERVIEW
    • NEWS & EVENTS
      • PRESS RELEASES
      • EVENTS
      • PRESENTATIONS
    • STOCK INFORMATION
      • STOCK QUOTE & CHART
      • HISTORIC PRICE LOOKUP
      • INVESTMENT CALCULATOR
    • CORPORATE GOVERNANCE
      • DOCUMENTS & CHARTERS
      • BOARD OF DIRECTORS
      • MANAGEMENT
      • COMMITTEE COMPOSITION
    • FINANCIALS & FILINGS
      • SEC FILINGS
    • RESOURCES
      • INVESTOR FAQs
      • EMAIL ALERTS
      • IR INQUIRY
Search this website

SCHEDULE 13G: SCHEDULE 13G – Description

  • Post author:Allogene Therapeutics SEC Filings
  • Post published:August 7, 2026
  • Post category:Uncategorized

Allogene Therapeutics, Inc.

Continue ReadingSCHEDULE 13G: SCHEDULE 13G – Description

Allogene Therapeutics Conference Call

  • Post author:Allogene Therapeutics
  • Post published:April 10, 2026
  • Post category:Uncategorized

The Investor Relations website contains information about Allogene Therapeutics's business for stockholders, potential investors, and financial analysts.

Continue ReadingAllogene Therapeutics Conference Call

The Allogene Therapeutics Fourth Quarter 2025 Conference Call

  • Post author:Allogene Therapeutics
  • Post published:March 12, 2026
  • Post category:Uncategorized

The Investor Relations website contains information about Allogene Therapeutics's business for stockholders, potential investors, and financial analysts.

Continue ReadingThe Allogene Therapeutics Fourth Quarter 2025 Conference Call

TD Cowen 46th Annual Health Care Conference

  • Post author:Allogene Therapeutics
  • Post published:March 3, 2026
  • Post category:Uncategorized

The Investor Relations website contains information about Allogene Therapeutics's business for stockholders, potential investors, and financial analysts.

Continue ReadingTD Cowen 46th Annual Health Care Conference

Citi’s 2026 Virtual Oncology Leadership Summit

  • Post author:Allogene Therapeutics
  • Post published:February 18, 2026
  • Post category:Uncategorized

The Investor Relations website contains information about Allogene Therapeutics's business for stockholders, potential investors, and financial analysts.

Continue ReadingCiti’s 2026 Virtual Oncology Leadership Summit

Piper Sandler 36th Annual Healthcare Conference

  • Post author:Allogene Therapeutics
  • Post published:December 3, 2024
  • Post category:Uncategorized

The Investor Relations website contains information about Allogene Therapeutics's business for stockholders, potential investors, and financial analysts.

Continue ReadingPiper Sandler 36th Annual Healthcare Conference

December 3, 2024 8:00 AM EST : Piper Sandler 36th Annual Healthcare Conference

  • Post author:Allogene Therapeutics Events
  • Post published:December 3, 2024
  • Post category:Uncategorized

Continue ReadingDecember 3, 2024 8:00 AM EST : Piper Sandler 36th Annual Healthcare Conference

The Citizens JMP Hematology and Oncology Summit

  • Post author:Allogene Therapeutics
  • Post published:December 2, 2024
  • Post category:Uncategorized

The Investor Relations website contains information about Allogene Therapeutics's business for stockholders, potential investors, and financial analysts.

Continue ReadingThe Citizens JMP Hematology and Oncology Summit

December 2, 2024 11:00 AM EST : The Citizens JMP Hematology and Oncology Summit

  • Post author:Allogene Therapeutics Events
  • Post published:December 2, 2024
  • Post category:Uncategorized

Continue ReadingDecember 2, 2024 11:00 AM EST : The Citizens JMP Hematology and Oncology Summit

Jefferies London Healthcare Conference

  • Post author:Allogene Therapeutics
  • Post published:November 20, 2024
  • Post category:Uncategorized

The Investor Relations website contains information about Allogene Therapeutics's business for stockholders, potential investors, and financial analysts.

Continue ReadingJefferies London Healthcare Conference
  • Go to the previous page
  • 1
  • 2
  • 3
  • Go to the next page
Allogene

CONNECT

210 E. Grand Avenue
South San Francisco, CA 94080

Phone: 650-457-2700

View Map / Contact Us

LinkedIn
X (Twitter)
  • PIPELINE
    • AlloCAR T Product Pipeline
    • THE ALPHA3 TRIAL
    • THE RESOLUTION TRIAL
    • DATABRIEF
    • Expanded Access
  • SCIENCE
    • Next Revolution in Cell Therapy
    • Platform for Tomorrow
    • On-Demand Availability
    • Scientific Publications
  • ABOUT US
    • At a Glance
    • Management Team
    • Board of Directors
    • Scientific Advisors
    • Partners
    • Corporate Responsibility
  • NEWS CENTER
    • Press Releases
    • Events
    • Perspectives
    • Social Media
    • Community Guidelines
  • INVESTORS
    • Press Releases
    • Events
    • Presentations
    • Stock Information
    • Stock Quote & Chart
    • Historical Price Look Up
    • Investment Calculator
    • Corporate Governance
    • Documents & Charters
  • INVESTORS
    • Board of Directors
    • Management
    • Committee Composition
    • SEC Filings
    • Resources
    • Investor FAQs
    • Email Alerts
    • IR Inquiry
Facebook
X (Twitter)
LinkedIn
E-Mail
Tumblr
Reddit
WhatsApp
Telegram
Allogene

CONNECT

210 E. Grand Avenue
South San Francisco, CA 94080

Phone: 650-457-2700

View Map / Contact Us

LinkedIn
X (Twitter)
  • PIPELINE
    • AlloCAR T Product Pipeline
    • THE ALPHA3 TRIAL
    • THE RESOLUTION TRIAL
    • DATABRIEF
    • Expanded Access
  • SCIENCE
    • Next Revolution in Cell Therapy
    • Platform for Tomorrow
    • On-Demand Availability
    • Scientific Publications
  • ABOUT US
    • At a Glance
    • Management Team
    • Board of Directors
    • Scientific Advisors
    • Partners
    • Corporate Responsibility
  • NEWS CENTER
    • Press Releases
    • Events
    • Perspectives
    • Social Media
    • Community Guidelines
  • INVESTORS
    • Press Releases
    • Events
    • Presentations
    • Stock Information
    • Stock Quote & Chart
    • Historical Price Look Up
    • Investment Calculator
    • Corporate Governance
    • Documents & Charters
  • INVESTORS
    • Board of Directors
    • Management
    • Committee Composition
    • SEC Filings
    • Resources
    • Investor FAQs
    • Email Alerts
    • IR Inquiry

©2026 ALLOGENE THERAPEUTICS

TERMS OF USE

COOKIE SETTINGS

PRIVACY NOTICE

©2026 ALLOGENE THERAPEUTICS

TERMS OF USE

COOKIE SETTINGS

PRIVACY NOTICE